Niskanen Center president Jerry Taylor wrote an op-ed for Fox News examining the collapse of Rand Paul’s campaign and what it means for the “libertarian movement.” He argued that the lack of larger support for Rand Paul revealed the weakness in the argument that the GOP is trending toward Libertarianism.
In a piece for the Foundation for Economic Education, vice president for policy Will Wilkinson argued that bad regulation, not capitalism, was what allowed Turing Pharmaceuticals to dramatically increase the price of Daraprim, a commonly used generic drug.
In a post at the Cato Institute’s Overlawyered blog, Walter Olson cited Will Wilkinson and the Niskanen Center in discussing how the FDA’s regulatory approach towards generic drugs created the monopoly for Daraprim that Turing Pharmaceuticals used to increase the price from $13.50 to $750.
On Red Alert Politics, Anthony Hennen cited the Niskanen Center and vice president for policy Will Wilkinson in arguing that the FDA regulatory structure allowed Turing Pharmaceuticals to increase the price of Daraprim from $13.50 to $750.
In an op-ed for The Hill, Niskanen analyst David Bier argued that the U.S. has seen more anti-immigrant activists resort to terrorism than refugees.
Civil Liberties / Technology:
In an article for Asia & Pacific Policy Society, Niskanen analyst Ryan Hagemann took a look at the progress made by Singapore on autonomous vehicles, and the lessons that could be learned by the region, the U.S., and the world.